Save time and get answers to complex questions with AI chat
Diltiazem drug class?Are there specific stretches to avoid while on lipitor?Dabrafenib patent expiration?Guselkumab loss of exclusitivy?Abbvie humira patent cliff navigation success?
See the DrugPatentWatch profile for Daclizumab
Two main brand names have been used for daclizumab, depending on indication: - Zenapax — for prevention of organ transplant rejection (e.g., kidney transplant). - Zinbryta — for relapsing multiple sclerosis. This product was withdrawn worldwide in 2018 due to safety concerns (liver injury), and is no longer marketed in most regions. Brand names can vary by country, but these are the primary ones you’ll see. If you have a specific indication or country in mind, I can confirm the current name used there.